A de novo dominant mutation in KIF1A associated with axonal neuropathy, spasticity and autism spectrum disorder by Tomaselli, PJ et al.
DOI: 10.1111/jns.12235 Journal of the Peripheral Nervous System 00:1–4 (2017)
CASE REPORT
A de novo dominant mutation in KIF1A associated with
axonal neuropathy, spasticity and autism spectrum
disorder
Pedro J. Tomaselli1,2, Alexander M. Rossor1, Alejandro Horga1, Matilde Laura1,
Julian C. Blake1, Henry Houlden3, and Mary M. Reilly1
1MRC Centre for Neuromuscular Diseases and National Hospital for Neurology and Neurosurgery, UCL Institute of
Neurology, London, UK; 2Department of Neuromuscular Disorders, Clinical Hospital of Ribeirão Preto, University of São
Paulo, Ribeirão Preto, SP, Brazil; and 3Department of Neurogenetics, The National Hospital for Neurology and Neurosurgery,
UCL Institute of Neurology, London, UK
Abstract Mutations in the kinesin familymember 1A (KIF1A) gene have been associated
with a wide range of phenotypes including recessive mutations causing hereditary sensory
neuropathy and hereditary spastic paraplegia and de novo dominant mutations causing
a more complex neurological disorder affecting both the central and peripheral nervous
system. We identiﬁed by exome sequencing a de novo dominant missense variant,
(c.38G>A, p.R13H), within an ATP binding site of the kinesin motor domain in a patient
manifesting a complex phenotype characterized by autism spectrum disorder (ASD), spastic
paraplegia and axonal neuropathy. The presence of ASD distinguishes this case from
previously reported patients with de novo dominant mutations in KIF1A.
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Introduction
Recessive mutations in the gene kinesin family
member 1A (KIF1A) have been reported as causative
of hereditary sensory neuropathy type 2C (OMIM:
614213) and hereditary spastic paraplegia type 30
(OMIM: 610357) (Riviere et al., 2011; Klebe et al.,
2012). KIF1A is a member of the kinesin family and
functions as an anterograde motor protein that trans-
ports membranous organelles along microtubules.
More recently, de novo dominant mutations have been
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shown to cause a complex phenotype characterized by
developmental delay, cerebellar ataxia, spasticity, and
peripheral neuropathy (Okamoto et al., 2014; Esmaeeli
Nieh et al., 2015; Ohba et al., 2015). Autism spectrum
disorder (ASD) is a neurodevelopmental disorder char-
acterized by deﬁcits in social interaction, language
and communication, and the presence of repetitive
or unusual behaviors (Levy et al., 2009). We report
a patient with a de novo missense variant in KIF1A
presenting with a complex phenotype characterized
by ASD, axonal neuropathy, and spasticity. This case
further expands the phenotype of dominant mutations
in K1F1A.
Case Report
A 20-year-oldmalewas seenwith early onset spas-
ticity, axonal neuropathy, and ASD. He is the second
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Table 1. Nerve conduction study (aged 18).
Right Left
Sensory NCS Amplitude (𝜇V) Conduction velocity (m/s) Amplitude (𝜇V) Conduction velocity (m/s)
Median 10 50 11 49
Ulnar 7 52 5 48
Radial 11 55 11 58
Sural Absent – Absent –
Superﬁcial Peroneal Absent – Absent –
Motor NCS Latency (ms) Amplitude (mV) Conduction velocity (m/s) F wave (ms)
Right median (APB) 3.6 9.7 50 30
Right ulnar (ADM) 3.0 8.3 51 31
Right common peroneal (EDB) Absent – – –
Right posterior tibial (AHL) 5.0 0.3 34 Absent
ADM, abductor digiti minimi; AHL, abductor halluces; APB, abductor pollicis brevis; EDB, extensor digitorum brevis; NCS, nerve conduction
study.
child of unrelated and healthy parents. He was born
at term but his developmental motor milestones were
delayed. At 3 years of age, he was noted to interact
poorly with other children. After starting main stream
school, he was diagnosed with attention deﬁcit and
hyperactivity disorder (ADHD) and displayed signiﬁ-
cant difﬁculties with written and spoken language and
was given a formal diagnosis of ASD. Additional fea-
tures of spasticity and neuropathy became evident in
adulthood. Neurological examination at age 20 demon-
strated normal cranial nerves with a positive jaw jerk
and pout reﬂex. The upper limbs were normal. He had
a spastic gait with in-turning of the feet, pes cavus, and
mild wasting of the intrinsic foot muscles but only mini-
mal weakness of ankle dorsiﬂexion. Sphincter function
was normal. Deep tendon reﬂexes were normal in the
upper limbs, but pathologically brisk in the lower limbs
with extensor plantar responses. Sensory examination
revealed reduced vibration sensation to the ankles but
was otherwise normal. Nerve conduction study at age
18 revealed a length-dependent sensory and motor
axonal neuropathy with signs of chronic denervation in
the lower limbs (Table 1).
We performed whole-exome sequencing in the
proband to determine the causative gene as previously
described using the Illumina Nextera rapid capture
focused enrichment kit and run on the Illumina HiSeq
2500 (Cottenie et al., 2014; Shigemizu et al., 2015).
Next-generation sequencing exome analyses
revealed 21,683 variants within coding regions or splic-
ing sites. Variants were ﬁltered for non-synonymous
and nonsense variants with a minor allele frequency
<0.5% in the The Exome Aggregation Consortium
(ExAC), 1.000 Genomes and Exoma Variant Server
(EVS) public databases, and for sequence quality (read
depth> 7), resulting in 420 variants. Additional ﬁltering
was performed for genes associated with neurological
diseases and seven variants were identiﬁed. One
heterozygous variant was detected in DHTKD1, a gene
associated with autosomal dominant CMT2Q but did
not segregate with the disease. Three heterozygous
variants in genes associated with autosomal recessive
disorders (LYST , PLEKHG5 and NEB) were identi-
ﬁed. Mutations in two additional genes associated
with distal myopathy and deafness (FLNC and GJB3)
were identiﬁed but were predicted benign using in
silico analysis. A novel missense mutation, c.38G>A;
p.R13H in K1F1A was identiﬁed (RefSeq assessing
number NM_001244008.1). This mutation is located
within a highly evolutionary conserved region both
between species and also among different kinesin
proteins (1 [KIF5B], 2 [KIF3A and KIF17], 3 [KIF1A],
4 [KIF4A], and 5 [KIF11]) where it forms part of the
ATP binding site (Fig. 1). Sanger sequencing of the
proband and parent’s DNA was performed as previ-
ously described (Liu et al., 2014), and conﬁrmed the
mutation had arisen de novo in the proband. The muta-
tion resides in the motor domain of KIF1A, providing
further evidence in support of the pathogenicity of this
novel mutation. In silico analysis using MutationTaster,
Polyphen-2, and SIFT predicted the p.R13Hmutation to
be pathogenic. This variant was not present in the Sin-
gle Nucleotide Polymorphism database (dbSNP), EVS,
NHLBI Exome Sequencing Project, 1000 Genomes
and ExAC databases. There were no additional variants
in known ASD-related genes.
Discussion
We describe a novel de novo dominant mutation
in the kinesin motor domain of KIF1A as a cause
of a complex neurodevelopmental disorder character-
ized by ASD, spasticity and axonal neuropathy. ASD
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Figure 1. Panel (A) shows the pedigree and chromatograms of the proband. Panel (B) shows that the arginine at position 13
of KIF1A is conserved from man to Xenopus. tropicalis and is also conserved across other kinesin proteins.
is a complex and poorly understood condition, and
approximately 10%–15% of cases are associated with
mutations in single genes (Levy et al., 2009). Several
genes (e.g., FMR1, MECP2, NLGN4X, and NLGN3)
have been implicated in ASD but none have been
reported in association with hereditary spastic paraple-
gia or axonal neuropathy.
KIF1A encodes a neuron-speciﬁc ATP-dependent
motor protein which is important for anterograde
axonal transport of cargo including synaptic vesicle
precursors (Okada et al., 1995; Lee et al., 2003), as
well as post-synaptic proteins involved in synaptic
plasticity (Lee et al., 2015). To date, recessive non-
sense mutations have been reported as causative
of hereditary sensory neuropathy with or without
minimal intellectual disability whereas recessive mis-
sense mutations in the motor domain are causative of
hereditary spastic paraplegia. De novo dominant muta-
tions within the motor domain have been reported in
association with complex phenotypes characterized by
intellectual disability and the variable presence of cere-
bellar atrophy, spastic paraparesis, optic nerve atrophy,
peripheral neuropathy, and epilepsy (Lee et al., 2015).
The p.R13H mutation is located in a highly con-
served residue within the ATP binding site, a region
necessary for the hydrolysis of ATP required for force
generation and vesicle transport along microtubules. In
utero, this mutation may affect cortical neuronal migra-
tion resulting in neurodevelopmental disorders such
as ASD. The p.S69L mutation in KIF1A has previously
been reported in a family with pure spastic paraplegia
and in whom the proband but not the affected father
had attention deﬁcit disorder. The authors concluded
it was not part of the phenotype as it did not seg-
regate with the mutation (Ylikallio et al., 2015), how-
ever, the presence of ASD in our case suggests that
it was probably part of the disorder. Mutations in the
retrograde transport protein, DYNC1H1, have already
been reported as a cause of ADHD, cortical migration
defects and motor neuropathy further highlighting the
importance of motor proteins in cortical andmotor neu-
ron development (Scoto et al., 2015). This case report
suggests that ASD and ADHD should be considered
within the phenotypic spectrum of dominantmutations
in KIF1A and further expands the spectrum of pheno-
types associated with KIF1A mutations.
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